By
Societatea Moldovei Împotriva Tuberculozei
Published: June 16, 2021, 12:30 a.m.·
Tags:
Drug-resistant TB,
Advocacy
STREAM is the first large-scale, multi-country clinical trial to investigate shortened regimens for multidrug-resistant TB (MDR-TB), and the first phase III trial to test the efficacy and safety of bedaquiline, a new drug with a novel mechanism of action, within a shortened treatment regimen.
Read More →